Asociacion de Beneficencia Hospital Sirio Libanes

Buenos Aires C1419AHN

0 studies enrolling now · 2 studies all time

What they study most

Metastatic Castration-sensitive Prostate Cancer, Urinary Bladder Neoplasms

Studies at this site

• A Study of TAR-200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in Participants With Muscle-invasive Bladder Cancer (MIBC) of the Bladder — Running, not enrolling
• A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for the Treatment of Participants With Deleterious Germline or Somatic Homologous Recombination Repair (HRR) Gene-Mutated Metastatic Castration-Sensitive Prostate Cancer (mCSPC) — Running, not enrolling